Uses of Coenzyme Q10 in Noncommunicable Diseases: Literature Review

Authors

  • Sirinapa Seangliw Institute of Complementary and Alternative Medicine, Department of Thai Traditional and Alternative Medicine

Keywords:

Noncommunicable diseases, Coenzyme Q10, Indications, Clinical trial, Elderly

Abstract

In Thailand, four noncommunicable diseases (NCDs), namely cancer, cardiovascular disease, diabetes, and chronic obstructive pulmonary disease, are the diseases with the highest mortality. The World Health Organization has identified noncommunicable diseases as a major challenge to reduce premature mortality from noncommunicable diseases by one third through prevention and treatment approaches. Thailand will be entered the super aged society, meaning that more than 28% of the population will be 60 years old or older in 2031. Hence, Thai public health should prepare to deal with health problems from old age and noncommunicable diseases. Anti-aging medicine aims to extend human longevity by preventing and slowing down aging by taking antioxidant supplements such as vitamins, minerals, coenzyme Q10, etc. This article has aimed to review the uses of Coenzyme Q10 in the treatment of NCDs, including definition, chemical structure, mechanism of action, clinical study results, side effects, warnings, drug interactions, and recommendations. The past 7-year literature review from the electronic databases; PubMed, ScienceDirect and Cochrane Library was conducted. Studies were selected based on titles, abstracts, full texts, and data collection, including systematic reviews and meta-analyses, clinical trials, and outcomes. The results were as follows: Coenzyme Q10 or ubiquinone is a nutrient for energy production in cell. Coenzyme Q10 has been used as a medicine for treatment various diseases and symptoms. According to the clinical trial data of Coenzyme Q10 demonstrated the efficiency for treatment various diseases and symptoms including cardiovascular disease, diabetes, kidney disease, neurodegenerative disease and inflammation. Moreover, it has been found to be safe without serious side effects. In Thailand, Coenzyme Q10 has been used as a co-adjuvant to standard drug therapy for congestive heart failure only. This review will contribute to current medical knowledge and can be used as basic information for those interested in conducting further research on treatment for all other noncommunicable diseases.

References

World Health Organization. Prevention and Control of Noncommunicable Diseases in Thailand - The Case for Investment [internet]. Nonthaburi: World Health Organization Thailand; [cited 2024 Dec 4]; [about 2 screens]. Available from: https://www.who.int/thailand/activities/NCDs_Investment_Case_Report

World Health Organization. Noncommunicable Diseases. [internet]. Thailand: World Health Organization Thailand [cited 2024 Dec 4]; [about 2 screens]. Available from: https://www.who.int/thailand/our-work/ NCDs

Thai Health Promotion Foundation. Society of people aged 60+. [internet]. Bangkok: Thai Health Promotion Foundation; [cited 2024 Dec 4]; [about 4 screens]. Available from: https://www.m-society. go.th/ewtadmin/ewt/mso_web/article_attach/20463/21073.pdf

Arora BP. Anti-aging medicine. Indian J Plast Surg 2008;41:S130-S3.

Saini R. Coenzyme Q10: The essential nutrient. J Pharm Bioallied Sci 2011;3(3):466-7.

Hernández-Camacho JD, Bernier M, López-Lluch G, Navas P. Coenzyme Q10 Supplementation in Aging and Disease. Front Physiol 2018;9:44.

Casagrande D, Waib PH, Junior AAJ. Mechanism of action and effects of the administration of coenzyme Q10 on metabolic syndrome. Journal of Nutrition & Intermediary Metabolism 2018;13:26-32.

Flowers N, Hartley L, Todkill D, Stranges S, Rees K. Co-enzyme Q10 supplementation for the primary prevention of cardiovascular disease. Cochrane Database Syst Rev 2014;2014(12):CD010405.

Mortensen SA, Rosenfeldt F, Kumar A, Dolliner P, Filipiak KJ, Pella D, et al. The effect of coenzyme Q10 on morbidity and mortality in chronic heart failure: results from Q-SYMBIO: a randomized double-blind trial. JACC Heart Fail 2014;2(6):641-9.

Alehagen U, Johansson P, Bjornstedt M, Rosén A, Dahlström U. Cardiovascular mortality and N-terminal-proBNP reduced after combined selenium and coenzyme Q10 supplementation: a 5-year prospective randomized double-blind placebo-controlled trial among elderly Swedish citizens. Int J Cardiol 2013;167(5):1860-6. 16.

Moradi M, Haghighatdoost F, Feizi A, Larijani B, Azadbakht L. Effect of Coenzyme Q10 Supplementation on Diabetes Biomarkers: a Systematic Review and Meta-analysis of Randomized Controlled Clinical Trials. Arch Iran Med 2016;19(8):588-96.

Alehagen U, Johansson P, Aaseth J, Alexander J, Brismar K. Increase in insulin-like growth factor 1 (IGF-1) and insulin-like growth factor binding protein 1 after supplementation with selenium and coenzyme Q10. A prospective randomized double-blind placebo-controlled trial among elderly Swedish citizens. PLoS One 2017;12(6):e0178614.

Rivara MB, Yeung CK, Robinson-Cohen C, Phillips BR, Ruzinski J, Rock D, et al. Effect of Coenzyme Q10 on Biomarkers of Oxidative Stress and Cardiac Function in Hemodialysis Patients: The CoQ10 Biomarker Trial. Am J Kidney Dis 2017;69(3):389-99.

Arun S, Liu L, Donmez G. Mitochondrial biology and neurological diseases. Curr Neuropharmacol 2016;14(2):143-54.

Schulz JB, Beal MF. Neuroprotective effects of free radical scavengers and energy repletion in animal models of neurodegenerative disease. Ann N Y Acad Sci 1995;765:100-10; discussion 116-8.

Mischley LK, Allen J, Bradley R. Coenzyme Q10 deficiency in patients with Parkinson's disease. J Neurol Sci 2012;318(1-2):72-5.

Liu J, Wang L, Zhan SY, Xia Y. Coenzyme Q10 for Parkinson's disease. Cochrane Database Syst Rev 2011;(12):CD008150.

Fan L, Feng Y, Chen GC, Qin LQ, Fu CL, Chen LH. Effects of coenzyme Q10 supplementation on inflammatory markers: a systematic review and meta-analysis of randomized controlled trials. Pharmacol Res 2017;119:128-36.

Abdollahzad H, Aghdashi MA, Asghari Jafarabadi M, Alipour B. Effects of coenzyme Q10 supplementation on inflammatory cytokines (TNF-alpha, IL-6) and oxidative stress in rheumatoid arthritis patients: a randomized controlled trial. Arch Med Res 2015;46(7):527-33.

Hathcock JN, Shao A. Risk assessment for coenzyme Q10 (Ubiquinone). Regul Toxicol Pharmacol 2006;45(3):282-8.

Cleveland Clinic. Coenzyme Q10 Capsules and Tablets. [internet]. Ohio: Cleveland Clinic; [cited 2024 Dec 4]; [about 1 screen]. Available from: https://my.clevelandclinic.org/health/drugs/20097- coenzyme-q10-capsules-and-tablets

Nutritional Medicine Institute. Coenzyme Q10: A Review of Clinical Use and Efficacy. [internet]. UK: Institute; 2021 [cited 2024 Dec 4]; [about 3 screens]. Available from: https://www.nmi.health/coenzyme-q10-a-review-of-clinical-use-and -- efficacy/

WebMD. Coenzyme Q10 - Uses, Side Effects, and More [internet] [cited 2024 Dec 4]; [about 1 screen]. Available from: https://www.webmd.com/vitamins/ai/ingredientmono-938/coenzyme-q10

Food and Drug Administration, Ministry of Public Health. [internet]. Find authorized product information from "Food and Drug Administration". Nonthaburi: Food and Drug Administration; 2020. [cited 2024 Dec 4]; [about 4 screens]. Available from: https://www.fda.moph.go.th/?cate=DATA_DRUG&type=advance&fi=1&ww=coenzyme+Q10

Pravst I, Zmitek K, Zmitek J. Coenzyme Q10 contents in foods and fortification strategies. Crit Rev Food Sci Nutr 2010;50(4):269-80.

Downloads

Published

18-03-2026

How to Cite

1.
Seangliw S. Uses of Coenzyme Q10 in Noncommunicable Diseases: Literature Review. J DMS [internet]. 2026 Mar. 18 [cited 2026 Mar. 20];51(1):61-9. available from: https://he02.tci-thaijo.org/index.php/JDMS/article/view/274575

Issue

Section

Original Article